Research I 10 September 2025
Our Solid Tumours preprint is now available online
We are thrilled to share a big milestone for EuroACT!
Our Solid Tumours preprint is now available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5390471
This study analysed 20,658 clinical trials across 12 tumour types in Europe, uncovering substantial geographic inequities in the use of Patient-Reported Outcome Measures (PROMs). Results show higher PROM adoption in Western/Northern Europe, while Central/Eastern regions remain underrepresented, highlighting the need for targeted policy action to ensure equitable patient-centred care.
We sincerely thank the EuroACT Steering Committee members for their vision, leadership, and dedication in driving this project forward 💪 A special thanks also to Syreon Research Institute for their research contributions.
EuroACT shows that patient voices belong in informed policymaking
#EuroACT #ClinicalTrials #Oncology #PROMs #PatientAdvocacy
ABOUT THE PROJECT
EuroACT is a research project initiated by WECAN and the European Hematology Community. The project aims to understand the clinical trial landscape in the European region, based on data extracted from all relevant European clinical trial registers. Data from the past five years will unveil differences where clinical trials have been run in European countries and will describe how and which patient-reported outcomes (PROs) and quality-of-life (QoL) instruments have been used in clinical trials.
